Literature DB >> 25951558

Technical aspects of intestinal transplantation.

H Furukawa1, K Abu-Elmagd1, J Reyes1, B Nour1, A Tzakis1, S Todo1, T E Starzl1.   

Abstract

Since the advent of the potent immunosuppressive agent FK 506, intestinal transplantation has become a feasible therapeutic option for patients with irreversible intestinal failure. In this chapter, we present our clinical experience with intestinal transplantation, focusing on the technical aspects of both the donor and recipient operations. The logistics of the operative procedure have been described previously.

Entities:  

Year:  1993        PMID： 25951558

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN： 1090-3941


  6 in total

1.  Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness.

Authors:  K M Abu-Elmagd; J Reyes; J J Fung; G Mazariegos; J Bueno; C Janov; J Colangelo; A Rao; A Demetris; T E Starzl
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

2.  Intestinal transplantation in 31 adults.

Authors:  H Furukawa; K Abu-Elmagd; J Reyes; W Hutson; J Tabasco-Minguillan; R Lee; S Kusne; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1996-10       Impact factor: 1.066

3.  Effect of CMV serology on outcome after clinical intestinal transplantation.

Authors:  H Furukawa; S Kusne; K Abu-Elmagd; M Green; J Reyes; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1996-10       Impact factor: 1.066

4.  Influence of donor criteria on early outcome after intestinal transplantation.

Authors:  H Furukawa; C Smith; R Lee; A S Knisely; W Irish; J Reyes; K Abu-Elmagd; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

5.  Intestinal transplantation at the University of Pittsburgh: six-year experience.

Authors:  H Furukawa; J Reyes; K Abu-Elmagd; L Mieles; W Hutson; S Kocoshis; J Tabasco-Manguillan; R G Lee; A Knisley; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

6.  Cytomegalovirus disease in intestinal transplantation.

Authors:  H Furukawa; R Manez; S Kusne; K Abu-Elmagd; M Green; G Reyes; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.